U.S.-China trade agreement, U.K. election, Fed easing: stronger base case, but risks remain
A trio of market-relevant news hit the headlines within the space of 24 hours on Thursday: a trade agreement between Washington and Beijing, a decisive U.K. vote, and more monetary easing from the U.S. central bank. Our Global Chief Economist Frances Donald assesses if this will translate into a sunnier outlook for 2020.
A “phase 1” trade deal between the United States and China was reached last week, which means the much talked-about tariff hike scheduled for December 15 will no longer come into place. Meanwhile, the Conservative Party in the United Kingdom has won a healthy majority in a closely watched election, thereby removing market uncertainty regarding Brexit, at least for now. Crucially, the U.S. Federal Reserve (Fed) announced that it’ll add US$500 billion to its balance sheet by year end1—where markets are concerned, what’s not to like?
The removal of these tail risks certainly strengthens our conviction in our cautiously optimistic base-case scenario: The global economy is approaching an important inflection point after which we’ll see economic growth/stabilization taking place first in Europe, followed by the United States, and then China and the broader Asian region. These developments are supportive of our belief that it could be time to bring a little risk back to the table, particularly as the Fed and other global central banks are likely to maintain their extraordinarily accommodative stance and balance sheet expansion initiatives for a while. These exercises should keep bond yields stable and low.
However, while the threat of fresh tariffs and yet another inconclusive election in the United Kingdom had weighed on the outlook for 2020, we must note that they were by no means the biggest risks to our expectations for an economic rebound next year. While undoubtedly positive, Thursday’s news developments do little to reduce the fundamental risks to our outlook, namely, a double dose of economic weakness in China, a weaker U.S. consumer, and the structural ramifications of trade tensions and supply chain readjustments.
Notably, where the U.S.-China trade agreement is concerned, we don’t think it’s time to pop the champagne just yet. Here are three reasons why caution might still be warranted:
- This isn’t a finalized deal—even if both sides have agreed to complete discussions “as quickly as possible” and China has said it’ll work to set a date for signing a deal.2 In our view, there remains plenty of scope for things to go awry. In particular, details are particularly fuzzy on whether there will be rollbacks of existing tariffs.
- Details for “Phase 2” negotiations remain unclear, meaning uncertainty could return soon. Notably, the “phase 1” trade deal isn’t likely to define future U.S.-China trade relations.
- From a macroeconomic perspective, the most important issue here isn’t the impact of tariffs but the cost of shifting global supply chains and lost productivity as we embark on the multi-year transition to a new trade paradigm that’ll be ultimately be defined by trade relations between a few key countries.
Within this context, here’s a quick look at how the way we see the world has changed in the past week.
Our key investment views:
Core investment theme |
Change in conviction | Our view |
An inventory rebuild will support a mild to moderate H2 2020 recovery in global growth |
Modestly higher |
We believe the global manufacturing recession is partly a function of a front-loaded inventory shock that had been exacerbated by the trade shock. In our view, the restocking cycle was always going to proceed with or without a trade deal, but the removal of tariffs that were set to be implemented on December 15 could imply a faster inventory rebuild at the margin. |
Business confidence has bottomed in Europe and the United States; business investments begin trickling in thereafter |
Higher | The deterioration in business confidence globally was also likely to be front-loaded and had begun to turn positive. However, the latest developments probably imply the worst of geopolitical uncertainty is over (i.e., we should now see second derivative improvements on this front). This should contribute to a faster rebound in business confidence globally. |
Central banks to remain extraordinarily accommodative |
Higher | Lower geopolitical risk doesn’t imply less support from the Fed. With an additional US$500 billion of bill-buying adding to the Fed’s balance sheet through to year end, the U.S. central bank will have almost reversed its previous “taper” attempt entirely. We expect this to keep bond yields at the front end contained and becoming slightly steeper. We also continue to expect further Fed interest-rate cuts on the back of persistently weak inflation. |
Fiscal policy to become increasingly relevant |
Higher | We’ll add the United Kingdom to the growing list of countries likely to expand fiscal spending in the year ahead. |
Key risks
Key risk theme |
Change in conviction |
Our view |
A double dose of weakness in China |
Unchanged | Our concerns about China relate mostly to domestic policies and the local economy—the absence of a massive stimulus program to revive growth, the weak earnings picture in the industrials sector, and diminishing strength in the real estate segment. These relate to the domestic economic cycle, not trade. We believe this is the biggest risk to the global macro story in 2020. |
U.S. job growth loses momentum; a weaker U.S. consumer |
Unchanged | Leading indicators continue to suggest we’re in a late cycle and weaker structural growth in the United States could mean fewer job gains and a less active U.S. consumer. |
Geopolitical risk events remain elevated; supply chain disruptions continue |
Unchanged | We’re no closer to understanding what the long-term U.S.-China trade relations will look like. Similarly, as Washington continues to reassess its trade relations with its partners, trade tensions could easily return to the fore. |
Important disclosure
1 Bloomberg, as of December 12, 2019. 2 “U.S. and China Reach Initial Trade Deal”, New York Times, December 13, 2019.
Investing involves risks, including the potential loss of principal. Financial markets are volatile and can fluctuate significantly in response to company, industry, political, regulatory, market, or economic developments. These risks are magnified for investments made in emerging markets. Currency risk is the risk that fluctuations in exchange rates may adversely affect the value of a portfolio’s investments.
The information provided does not take into account the suitability, investment objectives, financial situation, or particular needs of any specific person. You should consider the suitability of any type of investment for your circumstances and, if necessary, seek professional advice.
This material, intended for the exclusive use by the recipients who are allowed to receive this document under the applicable laws and regulations of the relevant jurisdictions, was produced by, and the opinions expressed are those of, Manulife Investment Management as of the date of this publication, and are subject to change based on market and other conditions. The information and/or analysis contained in this material has been compiled or arrived at from sources believed to be reliable, but Manulife Investment Management does not make any representation as to their accuracy, correctness, usefulness, or completeness and does not accept liability for any loss arising from the use of the information and/or analysis contained. The information in this material may contain projections or other forward-looking statements regarding future events, targets, management discipline, or other expectations, and is only as current as of the date indicated. The information in this document, including statements concerning financial market trends, are based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Manulife Investment Management disclaims any responsibility to update such information.
Neither Manulife Investment Management or its affiliates, nor any of their directors, officers, or employees, shall assume any liability or responsibility for any direct or indirect loss or damage or any other consequence of any person acting or not acting in reliance on the information contained herein. All overviews and commentary are intended to be general in nature and for current interest. While helpful, these overviews are no substitute for professional tax, investment or legal advice. Clients should seek professional advice for their particular situation. Neither Manulife, Manulife Investment Management, nor any of their affiliates or representatives is providing tax, investment, or legal advice. Past performance does not guarantee future results.
This material was prepared solely for informational purposes, does not constitute a recommendation, professional advice, an offer, or an invitation by or on behalf of Manulife Investment Management to any person to buy or sell any security or adopt any investment strategy, and is no indication of trading intent in any fund or account managed by Manulife Investment Management. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment. Diversification or asset allocation does not guarantee a profit nor protect against loss in any market. Unless otherwise specified, all data is sourced from Manulife Investment Management.
Manulife Investment Management
Manulife Investment Management is the global wealth and asset management segment of Manulife Financial Corporation. We draw on more than 150 years of financial stewardship to partner with clients across our institutional, retail, and retirement businesses globally. Our specialist approach to money management includes the highly differentiated strategies of our fixed-income, specialized equity, multi-asset solutions, and private markets teams—along with access to specialized, unaffiliated asset managers from around the world through our multimanager model.
These materials have not been reviewed by, are not registered with any securities or other regulatory authority, and may, where appropriate, be distributed by the following Manulife entities in their respective jurisdictions. Additional information about Manulife Investment Management may be found at manulifeam.com.
Australia: Hancock Natural Resource Group Australasia Pty Limited, Manulife Investment Management (Hong Kong) Limited. Brazil: Hancock Asset Management Brasil Ltda. Canada: Manulife Investment Management Limited, Manulife Investment Management Distributors Inc., Manulife Investment Management (North America) Limited, Manulife Investment Management Private Markets (Canada) Corp. China: Manulife Overseas Investment Fund Management (Shanghai) Limited Company. European Economic Area and United Kingdom: Manulife Investment Management (Europe) Ltd., which is authorized and regulated by the Financial Conduct Authority, and Manulife Investment Management (Ireland) Ltd., which is authorized and regulated by the Central Bank of Ireland. Hong Kong: Manulife Investment Management (Hong Kong) Limited. Indonesia: PT Manulife Aset Manajemen Indonesia. Japan: Manulife Asset Management (Japan) Limited. Malaysia: Manulife Investment Management (M) Berhad (formerly known as Manulife Asset Management Services Berhad) 200801033087 (834424-U) Philippines: Manulife Asset Management and Trust Corporation. Singapore: Manulife Investment Management (Singapore) Pte. Ltd. (company registration no. 200709952G) Switzerland: Manulife IM (Switzerland) LLC. Taiwan: Manulife Investment Management (Taiwan) Co. Ltd. Thailand: Manulife Asset Management (Thailand) Company Limited. United States: John Hancock Investment Management LLC, Manulife Investment Management (US) LLC, Hancock Capital Investment Management, LLC, and Hancock Natural Resource Group, Inc. Vietnam: Manulife Investment Fund Management (Vietnam) Company Limited.
Manulife Investment Management, the Stylized M Design, and Manulife Investment Management & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates, under license.
505996
